URIST MARSHALL (EVP & Co-Head Research & Inv.) received a stock award from ROYALTY PHARMA PLC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/7/2026ACC: 0001838139-26-000024
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
+5.25K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
8.25K acquired · 3K disposed
Non-Derivative Transactions1
Class A Ordinary Shares
Direct
Shares
+8.25K
Price / share
—
Trade value
—
% of position
New position
8/5/2026
0.00→8.25K
Total
Net shares
+8.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares Direct | 8/5/2026 | A · Award | +8.25K | — | — | New position | 0.00 | 8.25K |
| Total | +8.25K | $0.00 | ||||||
Derivative Transactions1
LP interests in RPI US Partners 2019, LP
Indirect
Converts to
Class A Ordinary Shares
30K shares
Shares
−3K
Strike price
Held after
244.41K
Exercisable
—
8/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| LP interests in RPI US Partners 2019, LP Indirect | Class A Ordinary Shares30K shares | 8/7/2026 | G · Gift | −3K | — | 244.41K |
Non-Derivative Holdings (Post-Transaction)1
Class A Ordinary Shares
IndirectShares owned19.02K
Total
19.02K indirect19.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Ordinary Shares | 19.02K | Indirect |
| Total | 19.02K | 19.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported